A drug used to treat certain types of chronic myeloid leukemia and acute lymphoblastic leukemia. Sprycel is also being studied in the treatment of certain other blood diseases and types of cancer. Sprycel binds to and blocks BCR-ABL and other proteins that help cancer cells grow. It is a type of tyrosine kinase inhibitor. Also called BMS-354825 and dasatinib.